SciHub
文献互助
期刊查询
一搜即达
科研导航
即时热点
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
裴根芝士卷
Lv3
210 积分
2022-12-01 加入
最近求助
最近应助
互助留言
Development and validation of a liquid chromatography-tandem mass spectrometry method for the determination of polymixin B1, B2, ile-B1, E1, and E2 in human plasma and its clinical pharmacokinetic application
2个月前
已完结
Simultaneous determination of almonertinib and its active metabolite HAS-719 in human plasma by LC-MS/MS: Evaluation of pharmacokinetic interactions
5个月前
已完结
Simultaneous determination of alflutinib and its active metabolite in human plasma using liquid chromatography-tandem mass spectrometry
5个月前
已完结
How to manage the dose of drugs in cancer patients with acute kidney injury, practical recommendations
6个月前
已完结
Prevalence of aggressive care among patients with cancer near the end of life: a systematic review and meta-analysis
7个月前
已完结
Application of longitudinal exposure-response modelling to support dacomitinib starting dose in patients with EGFR mutation-positive NSCLC
11个月前
已完结
Effect of First-Line Serplulimab vs Placebo Added to Chemotherapy on Survival in Patients With Extensive-Stage Small Cell Lung Cancer: The ASTRUM-005 Randomized Clinical Trial
1年前
已完结
Serplulimab Plus Chemotherapy vs Chemotherapy for Treatment of US and Chinese Patients with Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis to Inform Drug Pricing
1年前
已完结
Cost-effectiveness of the addition of CDK4/6 inhibitors to standard endocrine therapy in first-line treatment of women with advanced HR+/HER2- breast cancer in Mexico
1年前
已完结
Cost Effectiveness of CDK4/6 Inhibitors in the First-Line Treatment of HR+/HER2- Metastatic Breast Cancer in Postmenopausal Women in the USA
1年前
已完结
没有进行任何应助
感谢,点赞
2个月前
感谢,点赞
5个月前
感谢,点赞,速度真快
5个月前
感谢,点赞,速度真快
6个月前
感谢,点赞,速度真快
7个月前
感谢,点赞,速度真快
11个月前
感谢,点赞,速度真快
1年前
感谢,点赞,速度真快
1年前
感谢,点赞,速度真快
1年前
感谢,点赞,速度真快
1年前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论